Effect of marine collagen peptide on the expression of overoxidation stress markers in rats with type 2 diabetes

Gui-qin Liu,Cui-feng Zhu,Yan-fei Li,Hong-bin Peng,Hong Lu,Song-chao Guo,Fan Zhang,Yong Li

DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.23.024

2008-01-01

Abstract:Background: Marine collagen peptide is a kind of oligopeptide powder at the relative molecular mass of less than 1 000, comprising 2-6 amino acids. Its antioxidation property has been proved in vitro. Objective: To study the effect of marine collagen peptide on the expression of overoxidation stress markers in the blood serum of rats with type 2 diabetes. Design, time and setting: A randomized control animal study was carried out from October 2006 to June 2007 at the Laboratory of Animal Experiment in Shenzhen Center for Disease Control and Prevention (Shenzhen, Guangdong, China). Materials: Marine collagen peptide was offered by the China National Research Institute of Food and Fermentation Industry. Thirty-six male SD rats were assigned into 6 controls and 30 models. Normal control group fed with basal diet, while 26 of other 30 rats were successfully induced the model of type 2 diabetes by intraperitoneal injection of streptozotocin. Methods: Twenty-four rats with type 2 diabetes were randomly divided into four groups, namely marine collagen peptide low dose group (0.75 g/ kg ·d), medium dose group (1.5 g/kg ·d), high dose group (3.0 g/kg ·d) and diabetes control group. They were all processed into intragastric administration of tap water for 4 weeks. Main outcome measures: Blood glucose of rats before intervention and at four weeks after intervention. Blood level of superoxide dismutase (SOD), malondialdehyde (MDA), reduced glutathione hormone (GSH) and NO of rats at four weeks after intervention. Results: There were no significant differences among three marine collagen peptide groups on the blood glucose (P > 0.05). Compared to normal control group, the levels of SOD and GSH of all groups were significantly lowered, while the levels of MDA and NO were significantly enhanced (P < 0.01, 0.05); Compared to the diabetes control group, the SOD and GSH levels of marine collagen peptide middle and high dose groups were significantly increased, while the MDA and NO levels were significantly lowered (P < 0.01, 0.05). Conclusion: Higher dosage of marine collagen peptide (≥ 1.5 g/kg ·d) may have a regulating effect on the expression of overoxidation markers in rats with type 2 diabetes. The exact effect of marine collagen peptide on fasting blood glucose deserves further study of large scale samples and intervention time.